The RSI Oscillator for CLVR moved out of oversold territory on November 24, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on November 27, 2023. You may want to consider a long position or call options on CLVR as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CLVR just turned positive on October 31, 2023. Looking at past instances where CLVR's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLVR advanced for three days, in of 154 cases, the price rose further within the following month. The odds of a continued upward trend are .
CLVR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLVR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CLVR entered a downward trend on November 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.130) is normal, around the industry mean (47.989). P/E Ratio (0.000) is within average values for comparable stocks, (60.542). CLVR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.883). CLVR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.178) is also within normal values, averaging (65.502).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a blank check company, which formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, recapitalization, and reorganization
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, CLVR has been loosely correlated with SNDL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CLVR jumps, then SNDL could also see price increases.
Ticker / NAME | Correlation To CLVR | 1D Price Change % | ||
---|---|---|---|---|
CLVR | 100% | +3.72% | ||
SNDL - CLVR | 56% Loosely correlated | +4.90% | ||
ACB - CLVR | 36% Loosely correlated | +1.80% | ||
OGI - CLVR | 33% Loosely correlated | +5.47% | ||
CGC - CLVR | 29% Poorly correlated | +10.36% | ||
GHSI - CLVR | 28% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To CLVR | 1D Price Change % |
---|---|---|
CLVR | 100% | +3.72% |
Pharmaceuticals (undefined stocks) | -5% Poorly correlated | +1.48% |
Pharmaceuticals: Other (undefined stocks) | -5% Poorly correlated | +1.61% |